Kimberly Gentile
Hoofd Techniek/Wetenschap/O&O bij BIOHAVEN LTD.
Vermogen: 3 M $ op 31-05-2024
Actieve functies van Kimberly Gentile
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOHAVEN LTD. | Hoofd Techniek/Wetenschap/O&O | - | - |
Portage Pharmaceutical Ltd.
 Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Operationeel Directeur | - | - |
Loopbaan van Kimberly Gentile
Eerdere bekende functies van Kimberly Gentile
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Directeur/Bestuurslid | - | 03-10-2022 |
| Corporate Officer/Principal | 01-02-2014 | 03-10-2022 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2000 | 01-02-2014 |
| SCIREX Corp. | Corporate Officer/Principal | 01-01-1996 | 01-06-2000 |
Opleiding van Kimberly Gentile
| Salem State University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIOHAVEN LTD. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
| SCIREX Corp. | Commercial Services |
Portage Pharmaceutical Ltd.
Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
- Beurs
- Insiders
- Kimberly Gentile
- Ervaring
